These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9152532)

  • 1. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
    Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
    J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
    Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
    Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could somatostatin scintigraphy be superior to MIBG scan in the staging of stage IVs neuroblastoma (Pepper's syndrome)?
    Manil L; Edeline V; Michon J; Neuenschwander S; Lequen H; Lavocat C; Zucker JM
    Clin Nucl Med; 1996 Jul; 21(7):530-3. PubMed ID: 8818464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of MIBG and pentetreotide scintigraphy in children with neuroblastoma. Is the expression of somatostatin receptors a prognostic factor?
    Kropp J; Hofmann M; Bihl H
    Anticancer Res; 1997; 17(3B):1583-8. PubMed ID: 9179198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information.
    Schilling FH; Bihl H; Jacobsson H; Ambros PF; Martinsson T; Borgström P; Schwarz K; Ambros IM; Treuner J; Kogner P
    Med Pediatr Oncol; 2000 Dec; 35(6):688-91. PubMed ID: 11107147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
    Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
    Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the utility of
    Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
    Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
    Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
    Schmidt M; Simon T; Hero B; Schicha H; Berthold F
    Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
    Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
    Boubaker A; Bischof Delaloye A
    Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.
    Lastoria S; Maurea S; Caracò C; Vergara E; Maurelli L; Indolfi P; Casale F; di Tullio MT; Salvatore M
    Eur J Nucl Med; 1993 Dec; 20(12):1161-7. PubMed ID: 8299651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma in adults and adolescents: an indolent course with poor survival.
    Franks LM; Bollen A; Seeger RC; Stram DO; Matthay KK
    Cancer; 1997 May; 79(10):2028-35. PubMed ID: 9149032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.
    Reuland P; Geiger L; Thelen MH; Handgretinger R; Haase B; Müller-Schauenburg W; Niethammer D; Bares R
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):437-42. PubMed ID: 11878578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.